Clinical trials recruiting for Type 1 Diabetes Mellitus
15
Recruiting trials
22
US states with sites
13
Countries
20%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Teplizumab | 2 |
| Antithymocyte Globulin (ATG) | 1 |
| Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor | 1 |
| Tirzepatide | 1 |
| Tirzepatide 2.5mg weekly | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Colorado | 3 |
| Connecticut | 3 |
| Texas | 3 |
| California | 2 |
| Florida | 2 |
| Georgia | 2 |
| Illinois | 2 |
| Indiana | 2 |
| Minnesota | 2 |
| New York | 2 |
| Tennessee | 2 |
| Washington | 2 |
Top cities
Aurora, Colorado 3New Haven, Connecticut 3Atlanta, Georgia 2Chicago, Illinois 2Indianapolis, Indiana 2Minneapolis, Minnesota 2Seattle, Washington 2Arden, North Carolina 1Austin, Texas 1Baltimore, Maryland 1
Self-screener
Recruiting trials
- A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
- Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
- Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes
- Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
- Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes
- Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
- Feasibility of a Tailored Online Self-compassion Intervention
- GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
- Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Polycystic Ovary Syndrome in Type 1 Diabetes
- Simultaneous Measurement and Responsive Treatment - Part 2
- The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions
- The Skin Barrier in Users of Diabetes Devices
- Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Related conditions
Trials recruiting for Type 1 Diabetes Mellitus often also study these conditions. Each links to its own recruiting-trial list.
Type 2 diabetes 891Type 1 diabetes 31T1D 3Obesity 1512Type 2 Diabetes (T2DM) 16Rheumatoid arthritis 314Polycystic Ovary Syndrome (PCOS) 16PCOS 106Inflammatory Arthritis 9Healthy Volunteer 19
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Type 1 Diabetes Mellitus trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.